MedPath

A study to assess the action of belladonna and bryonia alba on inflammatory modulations produced in cases of rheumatoid arthritis through c reactive protein analysis

Phase 3
Completed
Conditions
Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
Registration Number
CTRI/2022/06/043589
Lead Sponsor
HOMOEOPATHY UNIVERSITY
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
87
Inclusion Criteria

1Clinically diagnosed patients of rheumatoid arthritis Previously Diagnosed cases of Rheumatoid arthritis reoccurring, with other medicine with no avail.

2Patient’s having CRP variations

3Patients of age group below 65 years and both the sexes will be considered.

4Patient giving consent and maintaining follow up

Exclusion Criteria

1Patients having extra articular manifestations

2Patient are not giving consent and maintaining follow up

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath